4//SEC Filing
MacKay-Dunn R. Hector 4
Accession 0001600620-23-000018
CIK 0001600620other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:16 PM ET
Size
11.8 KB
Accession
0001600620-23-000018
Insider Transaction Report
Form 4
MacKay-Dunn R. Hector
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-18+8,733→ 19,733 total - Sale
Common Stock
2023-05-23$11.26/sh−4,818$54,251→ 24,225 total - Exercise/Conversion
Restricted Stock Units
2023-05-18−8,733→ 0 totalFrom: 2023-05-18→ Common Stock (8,733 underlying) - Award
Common Stock
2023-05-19+9,310→ 29,043 total - Award
Stock Option (right to buy)
2023-05-19+15,234→ 15,234 totalExercise: $10.74Exp: 2033-05-19→ Common Stock (15,234 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
- [F2]Represents grant of the RSUs payable solely in common stock of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
- [F3]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.
- [F4]The option vests in twelve equal monthly installments commencing on June 19, 2023.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001838521
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 5:16 PM ET
- Size
- 11.8 KB